NFKB1 and meningioma: To determine the influence on inhibition of the ILK, one of the key components that regulate the three perturbed pathways namely Integrin, PI3K-Akt, and NF-κB, we have used the ILK inhibitor Cpd22 (Merck Millipore) on both meningioma patient-derived primary cell line as well as Ben-Men1.